The spine is a high-risk site for advanced tumor metastasis. The vertebral metastatic tumor commonly originates from lung cancer, breast cancer, gastrointestinal malignant tumor, prostate cancer, lymphoma and renal cancer (
8). Thoracic and lumbar vertebrae are common sites of spinal metastases, with thoracic vertebrae being the most common (70%), followed by lumbar vertebrae (20%) and cervical vertebrae (10%) (
9). Vertebral metastases often invade the sclerotin to cause osteolytic destruction, resulting in vertebral pathological fractures, spinal instability, spinal cord and nerve root compression and other complications. These complications often require surgical treatment (
2). Minimally invasive surgery has become an important treatment for spinal metastases (
3). Percutaneous vertebroplasty (PVP) is an important tool for minimally invasive surgery and can be treated with PVP and PKP (
10-
13).
PVP was first used in clinical practice in 1985. Because of its advantages such as significant pain relief, short time, less bleeding, and quick recovery, PVP has been widely used and achieved good results (
14-
22). The most common complication of PVP is bone cement leakage, and its incidence is up to 11% - 76% (
23,
24). It most often occurs in vertebral bone damage or weakness (
25,
26). The leakage rate of spinal metastases is often higher than that of osteoporotic vertebral fractures, which may be caused because tumor destructs cortical bone of the vertebral body or that tumor richens blood vessels and blood supply (
27). Percutaneous balloon dilatation vertebral kyphoplasty is improved based on PVP, which can reduce the leakage rate to 8.4% (
28-
31). In order to further reduce the leakage of bone cement, bone filling mesh bags were made.
In this study, the VAS scores of the two groups were lower than those before surgery, and the difference was statistically significant. There was no significant difference in VAS scores between the two groups. The Oswesty disability index at all time points after surgery was lower than that before operation, and the difference was statistically significant. There was no significant difference in Oswesty disability index between the two groups at the same time point. It shows that the use of bone filling mesh bags and simple percutaneous balloon dilatation vertebroplasty have good curative effects, which can effectively relieve pain and improve motor.
In this study, bone cement leakage was observed in only one patient in the bone filling mesh container vertebroplasty group, and the leakage rate was significantly lower than that in the PKP group. The mesh container used in the research is a newly developed domestic expandable mesh bag-shaped bone material filler, which is intertwined into a mesh tubular structure by polyethylene terephthalate (PET), so as to utilize the wrapping role of the net container to reduce the leakage of bone cement caused by traditional PVP. After the bone filling mesh container is placed in the vertebral body, the bone cement is directly injected into the mesh bag, and the bone cement causes the mesh container structure to slowly expand. Similar to the PKP balloon expansion, it could raise partial height of the vertebral body, improve the stability of the spine, so as to achieve the purpose of relieving pain; meanwhile, it could also make the bone cement extend into the trabecular bone gap to form a micro-locking, which hinders the further exudation of the bone cement, thereby reducing the leakage rate of the bone cement. Its mechanical action also blocks the blood supply of the tumor, allowing the tumor to form ischemic or congestive necrosis. When the bone cement reaches a temperature of 70°C during polymerization, it could directly kill the tumor, and the cytotoxicity of the monomer could also kill the tumor.
In summary, the bone filling mesh container group achieves satisfactory clinical results in terms of postoperative pain improvement, and greatly reduces the incidence of intraoperative cement leakage. Therefore, considering of the effectiveness and safety of the patient's surgery, bone filling mesh container technique could be a prior choice for the treatment of vertebral metastases with damaged posterior margin of the thoracolumbar vertebral body. However, the application time of bone filling mesh container technology in clinical practice is short, the related reports are few, the long-term follow-up data is insufficient, and it is unclear whether the dispersion and distribution of bone cement are limited. Therefore, large-sample, multi-center, and long-term follow-up studies are needed.